Daraxonrasib, a pancreatic cancer drug from Revolution Medicines, is showing unprecedented success. For patients like Leanna ...

FORMS, AND YOU MAY HAVE HEARD OF SOME GENE MUTATIONS LIKE BRCA1 OR BRCA2, BUT THERE’S ANOTHER ONE THAT YOU MAY NOT HAVE HEARD OF, AND IT’S CHEK2. MERCY MEDICAL CENTER DOCTOR NEIL FRIEDMAN JOINS US NOW ...

Sign up for Being Human, a newsletter that explores wellness culture, mortality and disease, and other mysteries of the body and the mind. “It’s a branding ...

The investigational KRAS G12D inhibitor zoldonrasib showed evidence of clinical activity and a favorable safety profile in ...

Immunotherapy is a revolutionary cancer treatment strategy that leverages the body’s immune system to fight cancer. While immune checkpoint inhibitors significantly improve the therapeutic outcomes in ...

Some 17 million Americans are living with genetic mutations tied to an increased risk of getting cancer, Cleveland Clinic researchers warned Monday. And the more than 3,400 mutations identified – ...

Researchers have created the first complete map showing how hundreds of mutations in a key cancer gene affect tumor growth. By testing every possible mutation in a critical hotspot, they found that ...

A new review from the Icahn School of Medicine at Mount Sinai and the Hospital Clínic de Barcelona provides one of the ...

A common mutation in the KRAS gene is associated with improved overall survival in pancreatic ductal adenocarcinoma (PDAC) compared with other variants, in part because the mutation appears to lead to ...

Ross Lamb had no idea that Angelina Jolie’s double mastectomy could have anything to do with his prostate cancer. Until he ...